In an era of ever-increasing cost and skills required to do complex diagnostics tests, Countable Labs (formerly Enumerix) is developing a next-generation genomics platform to make high resolution biology simple, fast, and affordable. Our goal is to reduce the cost of high resolution tests by at least 10 times to enable access to a broader patient population. We believe our team is poised to accomplish this. We are a group of seasoned biotech and innovative entrepreneurs, engineers, and scientists with a proven track record of advancing the field of genomics from innovation to commercial success. We have pioneered DNA microarrays, non-invasive prenatal screening using next generation sequencing (NGS), and high-throughput single-cell NGS, and together the founding team holds over 60 granted patents.
Location: United States
Total raised: $26M
Investors 1
| Date | Name | Website |
| 16.05.2025 | F-Prime Ca... | fprimecapi... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 01.06.2026 | - | $26M | ARCH Ventu... |
Mentions in press and media 7
| Date | Title | Description |
| 01.06.2026 | Countable Labs Secures $26M to Advance Precision Genomics with Countable PCR | Countable Labs just raised $26 million. This oversubscribed funding round accelerates commercialization of its Countable PCR technology. The platform offers single-molecule quantification, outperforming digital PCR in sensitivity and precis... |
| 01.06.2026 | Countable Labs Completes $26M Funding Round | PALO ALTO, CA, Countable Labs has announced the closing of an oversubscribed $26 million financing round. >> Click here for more funding data on Countable Labs >> To export Countable Labs funding data to PDF and Excel, click he... |
| 28.05.2026 | Countable Labs Raises $26 Million to Advance Single-Molecule PCR Technology | Funding Backs Next-Generation Genomic Measurement Tools Countable Labs raises $26 million to accelerate the development and commercial rollout of its single-molecule PCR technology. The round was led by ARCH Venture Partners, with participa... |
| 28.05.2026 | Countable Labs Raises $26 Million To Accelerate Countable PCR Commercialization | Countable Labs announced it has raised $26 million in an oversubscribed financing round to accelerate clinical product development and global commercialization of its Countable PCR technology. The financing round was led by ARCH Venture Par... |
| 28.05.2026 | Countable Labs Raises $26M in Funding | Countable Labs, the Palo Alto, Ca-based developer of Countable PCR, a single-molecule PCR technology, raised $26M in funding. The round was led by ARCH Venture Partners with participation from F-Prime Capital and Primer Ventures. The compan... |
| 15.09.2025 | The Scientist Unveils the 2025 Top Innovations Award Winners | The Scientist Top 10 Innovations of 2025 Fourteen breakthrough technologies are recognized across biotechnology, healthcare, lab tools, and startup innovations. WILMINGTON, Del., Sept. 15, 2025 /PRNewswire-PRWeb/ -- The Scientist proudly an... |
| - | Countable Labs | “Count DNA molecules with true single-molecule precision. Countable PCR delivers unmatched sensitivity and accuracy for genomics research. Learn more.” |